Co-expression carrier and eukaryon expressing carrier capable of inducing cell immune response
A technology of eukaryotic expression vectors and co-expression vectors, which is applied in the field of pGL3/CD80-P1A co-expression vectors and pcDNA3.1/B2M-IL15 eukaryotic expression vectors, can solve the problems of disappearance of immune stimulation and achieve the goal of overcoming immunogenic Sexually low effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] 1 Materials and methods
[0034] 1.1 Materials
[0035] Reagents: Various restriction endonucleases and T4 DNA ligase were purchased from Boehringer Mannheim Company; PCR reagents were purchased from TaKaRa Company; cell total RNA extraction reagent TRIZOL and reverse transcription reaction reagents were purchased from InVitrogen Company; DNA gel recovery kit and plasmid DNA isolation and purification kit from QIAGEN company; agarose from Promega company; yeast extract, tryptone from OXOID company; Lamda DNA Hind III marker (Huami company), 100bp DNA Marker (Tianwei Times company); single Nuclear cell separation solution LymphoprepTM (Axis-Shield polAS); MTT (Huami Corporation); ConA (purchased from Jingmei Corporation); Recombinant human IL-2 was purchased from PeproTech EC Ltd; R-PE labeled Pro5 MHC PentamerH-2L d / LPYLGWLVF, FITC-labeled rat anti-mouse CD8 monoclonal antibody (clone number: KT15) and P1A nonapeptide (LPYLGWLVF) were purchased from PROIMMUNE Company;...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 